Rocky Mountain Cancer Center — Denver, Colorado

Public research footprint of Rocky Mountain Cancer Center, compiled from the ClinicalTrials.gov public registry.

142

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · PDAC - Pancreatic Ductal Adenocarcinoma

Recently updated registry entries

NCT07573215 — Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic… (Available)
NCT04657068 — A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors (Recruiting)
NCT06722235 — A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Rocky Mountain Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.